Recombinant FGFR3 (Vofatamab Biosimilar) antibody

Catalog No. ABIN7675746

The Human Monoclonal anti-FGFR3 (Vofatamab Biosimilar) antibody (ABIN7675746) specifically detects FGFR3 (Vofatamab Biosimilar) in ELISA, FACS, BLI, Func and SPR. The antibody is reactive with Human samples.

Quick Overview for Recombinant FGFR3 (Vofatamab Biosimilar) antibody (ABIN7675746)

Target: FGFR3 (Vofatamab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This FGFR3 (Vofatamab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-FGFR3 (Vofatamab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-FGFR3 / CD333 Reference Antibody (vofatamab)

Characteristics: Anti-FGFR3 / CD333 Reference Antibody (vofatamab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for FGFR3 (Vofatamab Biosimilar)

Target: FGFR3 (Vofatamab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P22607